---
figid: PMC9704099__IRNF_A_2148539_F0001_C
pmcid: PMC9704099
image_filename: IRNF_A_2148539_F0001_C.jpg
figure_link: /pmc/articles/PMC9704099/figure/F0001/
number: Figure 1
figure_title: ''
caption: 'Renal function and histopathological changes in rats. (A, B) Detection of
  serum creatinine (SCr) and blood urea nitrogen (BUN) in rats by the sarcosine oxidase
  method and urease method, respectively. Data are expressed as mean ± SD, n = 6/group.
  ***p < .001 compared with the control group; ###p < .001 compared with the hypoxia
  injury group. (C) Histopathological changes in the kidney, including glomeruli,
  tubules, and renal interstitial (HE, PAS, and Masson staining, magnification 400×).'
article_title: Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting
  NF-κB signaling pathway in a PPARγ-dependent manner.
citation: Jun-Yu Wei, et al. Ren Fail. 2022;44(1):2056-2065.
year: '2022'

doi: 10.1080/0886022X.2022.2148539
journal_title: Renal Failure
journal_nlm_ta: Ren Fail
publisher_name: Taylor & Francis

keywords:
- Rosiglitazone
- PPARγ
- Hypoxia renal injury
- NF-κB
- apoptosis

---
